Morohoshi et al. [17] demonstrated significant increases in neutrophil elastase activity in both plasma and colonic mucosal tissues in UC patients, and showed that ONO-5046 (a specific inhibitor of neutrophil elastase) has therapeutic effects against DSS-induced colitis by reversing weight loss and spleen enlargement and reducing inflammation scores. Here, ELANE is linked to colitis.